Cargando…

Complement Mediated Endothelial Damage in Thrombotic Microangiopathies

Thrombotic microangiopathies (TMA) constitute a group of different disorders that have a common underlying mechanism: the endothelial damage. These disorders may exhibit different mechanisms of endothelial injury depending on the pathological trigger. However, over the last decades, the potential ro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blasco, Miquel, Guillén-Olmos, Elena, Diaz-Ricart, Maribel, Palomo, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082680/ https://www.ncbi.nlm.nih.gov/pubmed/35547236 http://dx.doi.org/10.3389/fmed.2022.811504

Ejemplares similares

Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)

Acute Pancreatitis: A Rare Cause of Complement-Mediated Thrombotic Microangiopathy
por: Livingston, Jonathan, et al.
Publicado: (2023)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Case Report: Chronic Lymphocytic Leukemia With Recurrent Complement-Mediated Thrombotic Microangiopathy and C3 Glomerulonephritis
por: Ma, Tiantian, et al.
Publicado: (2022)

Endothelial activation and damage as a common pathological substrate in different pathologies and cell therapy complications
por: Palomo, Marta, et al.
Publicado: (2023)

Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies
por: Hofer, Johannes, et al.
Publicado: (2014)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

Complement Factor I Mutation May Contribute to Development of Thrombotic Microangiopathy in Lupus Nephritis
por: Tseng, Min-Hua, et al.
Publicado: (2021)

Complement-Mediated Thrombotic Microangiopathy in a Patient With Antiphospholipid Syndrome and Anti-glomerular Basement Membrane Antibodies
por: Gallant, Tara L, et al.
Publicado: (2023)

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020)

Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report
por: Bruno, Valentina, et al.
Publicado: (2023)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Complement, thrombotic microangiopathy and disseminated intravascular coagulation
por: Kurosawa, Shinichiro, et al.
Publicado: (2014)

An Update in Drug-Induced Thrombotic Microangiopathy
por: Chatzikonstantinou, Thomas, et al.
Publicado: (2020)

P1642: OUTCOMES IN HOSPITALIZED PATIENTS WITH COMPLEMENT MEDIATED THROMBOTIC MICROANGIOPATHY
por: Logothetis, C., et al.
Publicado: (2022)

Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
por: Maitta, Robert W., et al.
Publicado: (2021)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
por: Gavriilaki, Eleni, et al.
Publicado: (2019)

The potential role of complements in cocaine-induced thrombotic microangiopathy
por: Dejman, Adriana, et al.
Publicado: (2018)

Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation
por: Acosta-Medina, Aldo A., et al.
Publicado: (2022)

Metabolism-Mediated Thrombotic Microangiopathy in an Older Patient Without Malnutrition
por: Shiraishi, Wataru, et al.
Publicado: (2023)

Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19
por: Wang, Xin, et al.
Publicado: (2020)

Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Clinical value of the renal pathologic scoring system in complement-mediated thrombotic microangiopathy
por: Chen, Fei-Fei, et al.
Publicado: (2023)

Complement-Mediated Thrombotic Microangiopathy and Spontaneous Splenic Rupture Associated With Cytomegalovirus Infection
por: Shabir, Sadia, et al.
Publicado: (2023)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation
por: Timmermans, Sjoerd A. M. E. G., et al.
Publicado: (2021)

Peering into the darkness of drug-induced thrombotic microangiopathy: complement, are you in there?
por: Sabulski, Anthony, et al.
Publicado: (2023)

Drug-induced Thrombotic Microangiopathy Caused by Gemcitabine
por: Hasan, Askari, et al.
Publicado: (2018)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Exploring the role of the complement system, endothelial injury, and microRNAs in thrombotic microangiopathy after kidney transplantation
por: Aleš Rigler, Andreja, et al.
Publicado: (2020)

Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Endothelial Dysfunction in Hematopoietic Cell Transplantation
por: Palomo, Marta, et al.
Publicado: (2019)

A Case of Thrombotic Microangiopathy Secondary to Hypertensive Emergency
por: Bandaru, Sai Samyuktha, et al.
Publicado: (2022)

Scleroderma Renal Crisis With Thrombotic Microangiopathy Treated With Eculizumab
por: Saba, Ludovic, et al.
Publicado: (2022)

Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series
por: Vitkauskaitė, Monika, et al.
Publicado: (2022)

Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy
por: Salhi, Sofiane, et al.
Publicado: (2020)

Thrombotic Microangiopathy After Kidney Transplantation: An Underdiagnosed and Potentially Reversible Entity
por: Ávila, Ana, et al.
Publicado: (2021)

Clinical Utility and Potential Cost Savings of Pharmacologic Monitoring of Eculizumab for Complement-Mediated Thrombotic Microangiopathy
por: Sridharan, Meera, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_78ug1gl6e95d46ucc51c7j51e8